Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumour necrosis factor-α in human glial cells

AIDS

Volumn 11, Issue 1, 1997, Pages

  Richard, Alain ^a   Robichaud, Gilles ^a   Lapointe, Réjean ^a   Bourgoin, Sylvain ^a   Darveau, André ^a   Poulin, Louise ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Glial cells; Nef; Tumour necrosis factor

Indexed keywords

CERAMIDE; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEF PROTEIN; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; ASTROCYTOMA; ASTROCYTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROLYSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CERAMIDES; DNA, NEOPLASM; ENZYME ACTIVATION; GENE PRODUCTS, NEF; GLIOMA; HIV-1; HUMANS; HYDROLYSIS; NEUROGLIA; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031016516     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199701000-00001     Document Type: Article

References (29)

1. Blumberg BM, Gelbard HA, Epstein LG: HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res 1994, 32:253-267.
2. Tornatore C, Meyers K, Atwood W, Conant K, Major E: Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994, 68:93-102.
3. Tornatore C, Nath A, Amemiya K, Major EO: Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 1991, 65:6094-6100.
4. Yang Z, Costanzo M, Golde DW, Kolesnick RN: Tumor necrosis factor activation of the sphingomyclin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J Biol Chem 1993, 268:20520-20523.
5. Sawai H, Okazaki T, Yamamoto H, et al.: Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 1995, 270:27326-27331.
6. Kestler HW, Ringler DJ, Mori K, et al.: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 17:651-662.
7. Trono D: HIV accessory proteins - leading roles for the supporting cast. Cell 1995, 82:189-192.
8. Poulin L, Levy JA: The HIV-1 nef gene product is associated with phosphorylation of a 46 kD cellular protein. AIDS 1992, 6:787-791.
9. Sawai ET, Baur A, Peterlin BM, Levy JA, Cheng-Mayer C: Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc Natl Acad Sci USA 1994, 91:1539-1543.
10. Saksela K, Cheng G, Baltimore D: Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 1995, 14:484-191.
11. Baur AS, Sawai ET, Dazin P, Fantl WJ, Cheng-Mayer C, Peterlin BM: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994, 1:373-384.
12. Smith BL, Krushelnycky BW, Mochly-Rosen D, Berg P: The HIV Nef protein associates with protein kinase C theta. J Biol Chem 1996, 271:16753-16757.
13. Poulin L, Fauchon M, Darveau A, Levy JA: Inhibition of protein synthesis by the human immunodeficiency virus type 1 nef gene product. J Gen Virol 1994, 75:2977-2984.
14. Moir S, Poulin L: Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay. AIDS Res Hum Retrovirus 1996, 12:811-820.
15. Gottschalk AR, McShan CL, Kilkus J, Dawson G, Quintans J: Resistance to anti-IgM-induced apoptosis in a WEHI-231 subline is due to insufficient production of ceramide. Eur J Immunol 1995, 25:1032-1038.
16. Lapointe R, Lemieux R, Olivier M, Darveau A: Tyrosine kinase and cAMP-dependent protein kinase activities in CD40-activated human B lymphocytes, Eur J Immunol 1996, 26:2376-2383.
17. Cheng-Mayer C, Weiss C, Seto D, Levy JA: Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Natl Acad Sci USA 1989, 86:8575-8579.
18. Poulin L, Fauchon M, Darveau A, Levy JA: Inhibition of protein synthesis by HIV-1 nef gene product, J Gen Virol 1994, 75:2977-2984.
19. Gulbins E, Bissonnette R, Mahboubi A, et al.: Fas-induced apoptosis is mediated via a ceramide-initiated ras signaling pathway. Immunity 1995, 2:341-351.
20. Spiegel S, Milstien S: Sphingolipid metabolites: members of a new class of lipid second messengers. J Membrane Biol 1995, 146:225-237.
21. Cuvillier O, Pirianov G, Kleuser B, et al.: Suppression of ceramide-mediated programmed cell-death by sphingosine-1-phosphate. Nature 1996, 381:800-803.
22. Smith BL, Krushelnycky BW, Mochly-Rosen D, Berg P: The HIV Nef protein associates with protein kinase C theta. J Biol Chem 1996, 271:16753-16757.
23. Mudie;ller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K: PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995, 16:1961-1969.
24. Dbaibo GS, Obeid LM, Hannun YA: Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. J Biol Chem 1993, 268:17762-17766.
25. De SK, Marsh JW: HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J Biol Chem 1994, 269:6656-6660.
26. Ratner L, Niederman TMJ: Nef. In Transacting Functions of Human Retroviruses. Edited by Chen IS, Koprowski H, Srinivasan A. New York: Springer Verlag; 1995:169-208.
27. Papp B, Zhang D, Groopman JE, Byrn RA: Stimulation of human immunodeficiency virus type 1 expression by ceramide. AIDS Res Hum Retrovirus 1994, 10:775-780.
28. Rivas CI, Golde DW, Vera JC, Kolesnick RN: Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cells. Blood 1994, 83:2191-2197.
29. De Simone C, Cifone MG, Roncaioli P, et al: Ceramide, AIDS and long-term survivors [letter]. Immunol Today 1996, 17:48.